Bexil Corporation Reports First Quarter 2022 Financial Results

Rhea-AI Summary

Bexil Corporation (BXLC) reported its Q1 2022 financial results, showing a decline in net income to approximately $0.14 million or $0.19 per diluted share, down from $2.19 million or $2.65 per diluted share in Q1 2021. The losses from equity security investments amounted to $0.30 million, contrasting with $1.86 million in gains from the previous year. The company's book value per share increased to $36.25 from $29.75. Investors are encouraged to review the full quarterly report for comprehensive insights.

Positive

• Book value per share rose to $36.25 from $29.75 YoY.
• Shareholder equity increased from $24.7 million to $27.3 million.

Negative

• Net income significantly decreased to $0.14 million from $2.19 million YoY.
• Losses from equity securities were $0.30 million compared to gains of $1.86 million.

MILLBROOK, NY / ACCESSWIRE / May 13, 2022 / Bexil Corporation (Stock Symbol:BXLC) ("Bexil" or the "Company") today reported its financial results for the first quarter ended March 31, 2022.

For the three months ended March 31, 2022, Bexil recorded net income attributable to Bexil shareholders of approximately $0.14 million or $0.19 of diluted earnings per share, compared to net income attributable to Bexil shareholders of approximately $2.19 million or $2.65 of diluted earnings per share for the three months ended March 31, 2021.

Generally Accepted Accounting Principles ("GAAP") require that the Company include the changes in unrealized gains/losses of its equity security investments in net income. Such investment gains/losses include losses of $0.30 million in the three months ended March 31, 2022 and gains of $1.86 million in the three months ended March 31, 2021. The amount of investment gains/losses in any given period is usually meaningless and delivers figures for net earnings per share that can be extremely misleading to investors who have little or no knowledge of accounting rules, as noted in a recent Berkshire Hathaway press release.

The Company's book value per share attributable to Bexil shareholders at March 31, 2022 was $36.25, based on shareholders' equity attributable to Bexil shareholders of approximately $27.3 million and 753,228 shares issued and outstanding. The Company's book value per share attributable to Bexil shareholders at March 31, 2021 was $29.75, based on shareholders' equity attributable to Bexil shareholders of approximately $24.7 million and 830,577 shares issued and outstanding.

The limited information above in this press release is not adequate for making an informed investment judgment, and we urge stockholders and investors to read the Company's unaudited quarterly report for the quarterly period ended March 31, 2022, which is available at www.Bexil.com appended to the copy of this press release and at www.otcmarkets.com under the Company's stock symbol.

About Bexil Corporation

The objective of Bexil Corporation, a holding company, is to increase book value per share over time for the benefit of its shareholders. The Company is primarily engaged through a wholly owned subsidiary, Bexil Advisers LLC, in investment management. Bexil Advisers is a registered investment adviser and the investment manager to Dividend and Income Fund, a closed end fund (Stock Symbol:DNIF) (NAV Symbol:XDNIX). To learn more about Bexil, including Rule 15c2-11 information, please visit www.Bexil.com.

Safe Harbor Note

This release may contain certain "forward looking statements" within the meaning of federal securities laws including, but not limited to the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Bexil, which may cause the Company's actual results to be materially different from those expressed or implied by such statements. The Company may also make additional forward looking statements from time to time. All such subsequent forward looking statements, whether written or oral, by the Company or on its behalf, are also expressly qualified by these cautionary statements. Investors should carefully consider the risks, uncertainties, and other factors, together with the information included in the Company's Annual Report, at http://www.bexil.com/cautionary-language.html, and similar information. All forward looking statements made herein are only made as of the date of this release, and the Company undertakes no obligation to publicly update such forward looking statements to reflect subsequent events or circumstances.

The Company views book value per share, a non-GAAP financial measure, as an important indicator of financial performance. Presented in conjunction with other financial information, the combined presentation can enhance an investor's understanding of the Company's underlying financial condition and results from operations. The definition of book value as presented in this press release is shareholders' equity attributable to Bexil shareholders divided by currently issued and outstanding shares.

CONTACT:
Thomas O'Malley
Chief Financial Officer
1-212-785-0900
tomalley@bexil.com
www.Bexil.com

SOURCE: Bexil Corporation

View source version on accesswire.com:
https://www.accesswire.com/701242/Bexil-Corporation-Reports-First-Quarter-2022-Financial-Results

FAQ

What were Bexil Corporation's Q1 2022 earnings results?

Bexil reported a net income of approximately $0.14 million or $0.19 per diluted share for Q1 2022, a significant decrease from $2.19 million or $2.65 per diluted share in Q1 2021.

How did Bexil's book value per share change in Q1 2022?

The book value per share increased to $36.25 in Q1 2022 from $29.75 in Q1 2021.

What were the losses from equity securities for Bexil in Q1 2022?

Bexil recorded losses of $0.30 million from equity securities in Q1 2022, compared to gains of $1.86 million in Q1 2021.

How does Bexil Corporation define book value per share?

Bexil defines book value per share as shareholders' equity attributable to Bexil shareholders divided by currently issued and outstanding shares.